General

The shift happened without a product launch, without a press release, and without a single pharmaceutical company authorizing it. Sometime

Walk into any pharmaceutical compliance team’s weekly meeting and you’ll find the same agenda items from the past decade: OPDP

Why migraine drugs became weight-loss forums, cholesterol pills turned into food-interaction experiments, and cancer therapies spawned Reddit-scale crowdsourced medicine. There’s

On September 30, 2004, Merck pulled Vioxx from every pharmacy shelf in the world. The withdrawal took less than 24

Chatbots now answer drug questions that once required a detail rep, a pharmacist, or a Medical Information call center. The

AI Pharmacovigilance: How Drug Companies Track Safety Signals Before Regulators Do The FDA receives roughly 2 million adverse event reports

If you want to understand drug shortages, don’t start with FDA dashboards. Start with patient questions. They don’t say “supply

A look at the $50B opportunity reshaping how pharma companies launch, monitor, and defend their brands in the age of

Physicians are increasingly asking AI chatbots how to dose drugs, manage contraindications, and choose between therapies. The AI answers. The

How pharmaceutical brands are losing control of patient conversations, clinical narratives, and competitive positioning inside the black box of generative

Drug companies spend billions crafting brand narratives. AI is rewriting them in real time — and most manufacturers have no

How artificial intelligence is tracking, shaping, and sometimes undermining pharmaceutical brand strategy — and what drug companies need to do